Literature DB >> 10891332

Enzyme destruction by a protease contaminant in bacitracin.

S Rogelj1, K J Reiter, L Kesner, M Li, D Essex.   

Abstract

Bacitracin, as purchased from biochemical supply companies, is a mixture of more than 30 different substances. The major antibiotic isoforms A and B account for about 60% of the mixture. A newly identified impurity in some, but not all, of the bacitracin lots is a powerful subtilisin-type protease capable of cleaving many proteins including protein disulfide isomerase (PDI), myosin, and a variety of artificial substrates Thus, it is important for investigators who use bacitracin as a protease or other enzyme inhibitor to determine if the bacitracin they are using is contaminated with a protease enzyme. If it is present, they may have to reinterpret their results and retest with an enzyme-free bacitracin reagent. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891332     DOI: 10.1006/bbrc.2000.3029

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?

Authors:  Martin McLaughlin; Koen Vandenbroeck
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

2.  A bacitracin-resistant Bacillus subtilis gene encodes a homologue of the membrane-spanning subunit of the Bacillus licheniformis ABC transporter.

Authors:  Reiko Ohki; Kozue Tateno; Youji Okada; Haruo Okajima; Kei Asai; Yoshito Sadaie; Makiko Murata; Toshiko Aiso
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

3.  Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry.

Authors:  Shuguang Bi; Patrick W Hong; Benhur Lee; Linda G Baum
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

4.  Opposing effects of bacitracin on human papillomavirus type 16 infection: enhancement of binding and entry and inhibition of endosomal penetration.

Authors:  Samuel K Campos; Janice A Chapman; Martin J Deymier; Matthew P Bronnimann; Michelle A Ozbun
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

Review 5.  Protein disulfide isomerase as an antithrombotic target.

Authors:  Robert Flaumenhaft
Journal:  Trends Cardiovasc Med       Date:  2013-03-27       Impact factor: 6.677

6.  Disulfide isomerization switches tissue factor from coagulation to cell signaling.

Authors:  Jasimuddin Ahamed; Henri H Versteeg; Marjolein Kerver; Vivien M Chen; Barbara M Mueller; Philip J Hogg; Wolfram Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-07       Impact factor: 11.205

7.  Tissue factor activation: is disulfide bond switching a regulatory mechanism?

Authors:  Usha R Pendurthi; Samit Ghosh; Samir K Mandal; L Vijaya Mohan Rao
Journal:  Blood       Date:  2007-08-28       Impact factor: 22.113

8.  Cell surface protein disulfide isomerase regulates natriuretic peptide generation of cyclic guanosine monophosphate.

Authors:  Shuchong Pan; Horng H Chen; Cristina Correia; Haiming Dai; Tyra A Witt; Laurel S Kleppe; John C Burnett; Robert D Simari
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

9.  Regulation of nerve growth and patterning by cell surface protein disulphide isomerase.

Authors:  Geoffrey Mw Cook; Catia Sousa; Julia Schaeffer; Katherine Wiles; Prem Jareonsettasin; Asanish Kalyanasundaram; Eleanor Walder; Catharina Casper; Serena Patel; Pei Wei Chua; Gioia Riboni-Verri; Mansoor Raza; Nol Swaddiwudhipong; Andrew Hui; Ameer Abdullah; Saj Wajed; Roger J Keynes
Journal:  Elife       Date:  2020-05-28       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.